<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Amendment No.: *
Name of Issuer: Per-Se Technologies, Inc.
(formerly Medaphis Corporation)
Title of Class of Securities: Common Stock, $0.01 par value
CUSIP Number: 584028104
(Name, Address and Telephone Number of Person
Authorized To Receive Notices and Communications)
Peter Woodward, c/o Regan Partners, L.P.,
600 Madison Avenue, 26th Floor
New York, New York 10022; (212) 317-1646
(Date of Event which Requires Filing of this Statement)
October 31st, 2000
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box [ X ].
Note: Six copies of this statement, including all exhibits,
should be filed with the Commission. See Rule 13d-1(a) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No.: 584028104
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Regan Partners, L.P.
2. Check the Appropriate Box if a Member of a Group
a.
b. X
3. SEC Use Only
4. Source of Funds
WC
5. Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e)
6. Citizenship or Place of Organization
New Jersey
Number of Shares Beneficially Owned by Each Reporting Person
With:
7. Sole Voting Power:
0
8. Shared Voting Power:
1,755,000
9. Sole Dispositive Power:
0
10. Shared Dispositive Power:
1,755,000
11. Aggregate Amount Beneficially Owned by Each Reporting Person
1,755,000
2
<PAGE>
12. Check Box if the Aggregate Amount in Row (11) Excludes
Certain Shares
13. Percent of Class Represented by Amount in Row (11)
5.87%
14. Type of Reporting Person
PN
3
<PAGE>
CUSIP No.: 584028104
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Basil P. Regan
2. Check the Appropriate Box if a Member of a Group
a.
b. X
3. SEC Use Only
4. Source of Funds
WC
5. Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e)
6. Citizenship or Place of Organization
United States of America
Number of Shares Beneficially Owned by Each Reporting Person
With:
7. Sole Voting Power:
256,501
8. Shared Voting Power:
3,805,433
9. Sole Dispositive Power:
256,501
10. Shared Dispositive Power:
3,805,433
11. Aggregate Amount Beneficially Owned by Each Reporting Person
4,061,934
4
<PAGE>
12. Check Box if the Aggregate Amount in Row (11) Excludes
Certain Shares
13. Percent of Class Represented by Amount in Row (11)
13.58%
14. Type of Reporting Person
IN
5
<PAGE>
The purpose of this Schedule 13D is to (i) report the ownership
of Regan Partners, L.P. (the "Partnership") and Basil P. Regan
(together with the Partnership the "Reporting Persons") in the
Common Stock, $.01 par value (the "Shares"), of Per-Se
Technologies, Inc. (formerly Medaphis Corporation) (the "Issuer")
and (ii) to report the switch of the Reporting Persons from the
use of Schedule 13G to the use of Schedule 13D to report their
beneficial ownership in the Shares of the Issuer.
Item 1. Security and Issuer
The title of the class of equity securities to which
this statement relates is: Common Stock, $.01 par
value, in Per-Se Technologies, Inc. (formerly Medaphis
Corporation).
The name and address of the principal executive and
business office of the Issuer is:
Per-Se Technologies, Inc.
2840 Mt. Wilkinson Parkway
Suite 300
Atlanta, Georgia 30339
Item 2. Identity and Background
This statement is being filed on behalf of the Reporting
Persons. Mr. Regan is the general partner of Regan
Partners, L.P., a New Jersey limited partnership (the
"Partnership"), and is the principal of Regan Fund
Management Ltd., a New York corporation. Regan Fund
Management Ltd. is the investment manager of Regan
International Fund Limited, a British Virgin Islands
Corporation (the "International Fund"), and has
investment discretion over certain managed accounts, two
of which holds Shares of the Issuer (the "managed
account").
The Reporting Person has not, during the last five
years, been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors).
The Reporting Person has not, during the last five
years, been a party to a civil proceeding of a judicial
or administrative body of competent jurisdction which
resulted in a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws
or finding any violaitons with respect to such laws.
6
<PAGE>
Mr. Regan is a citizen of the Untied States of America.
Item 3. Source and Amount of Funds or Other Consideration
As of the date hereof, the Partnership owns 1,755,000
Shares; and Basil P. Regan is deemed to beneficially own
4,061,934 Shares.
All of the Shares were purchased in open market
transactions by the Reporting Persons.
The funds for the purchase of the Shares held in the
Partnership have come from the working capital of the
Partnership. No funds were borrowed to purchase any of
the Shares.
Item 4. Purpose of Transactions
The purpose of this Schedule 13D is to report the
Reporting Persons' change from using Schedule 13G to
report their beneficial ownership of Shares.
On October 31, 2000, Mr. Regan sent a letter to the
Board of Directors of the Issuer in which he registered
his discontent with the management of the Issuer.
Item 5. Interest in Securities of Issuer
As of the date hereof, the Partnership owns 1,755,000
Shares and Mr. Regan is deemed to be the beneficial
owner of 4,061,934 Shares. Based on the Issuer's filing
on Form 10-Q on September 30, 2000, there were
29,901,554 Shares outstanding. Therefore, the
Partnership owns 5.87% and Mr. Regan is deemed to
beneficially own 13.58% of the outstanding Shares. The
Reporting Persons have the sole or shared power to vote,
direct the vote, dispose of or direct the disposition of
all the Shares that they own or are deemed to
beneficially own.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer
No change.
7
<PAGE>
Item 7. Material to be Filed as Exhibits
1. An agreement relating to the filing of a joint
statement as required by Rule 13d-1(f) under
the Securities Exchange Act of 1934 is filed
herewith as Exhibit A.
2. A description of the transactions in the
Shares that were effected by the Reporting
Person during the 60 days prior to October 31,
2000 through November 30th, 2000 is filed
herewith as Exhibit B.
8
<PAGE>
Signature
The undersigned, after reasonable inquiry and to
the best of their knowledge and belief, certify that the
information set forth in this statement is true, complete
and correct.
REGAN PARTNERS, L.P.
By: /s/ Basil P. Regan
_______________________________
Basil P. Regan, General Partner
REGAN INTERNATIONAL FUND LIMITED
By: Regan Fund Management Ltd.
By: /s/ Basil P. Regan
_______________________________
Basil P. Regan, President
BASIL P. REGAN
/s/ Basil P. Regan
_________________________________
Basil P. Regan
December 6, 2000
9
<PAGE>
Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13D dated
December 6, 2000 relating to the Common Stock of Hanover
Direct, Inc. shall be filed on behalf of the undersigned.
REGAN PARTNERS, L.P.
By: /s/ Basil P. Regan
_______________________________
Basil P. Regan, General Partner
REGAN INTERNATIONAL FUND LIMITED
By: Regan Fund Management Ltd.
By: /s/ Basil P. Regan
_______________________________
Basil P. Regan, President
BASIL P. REGAN
/s/ Basil P. Regan
_______________________________
Basil P. Regan
10
<PAGE>
Exhibit B
Schedule of Transactions
Date Price Per Share Number of Shares
11-22-00 3.0946 25,000
11-24-00 3.1874 800
11-27-00 3.0874 15,000
11-28-00 3.1874 159,200
11-30-00 2.7822 20,000
11
01394002.AP9
